Demographic features of participants
| Demographics | (No.) (%) |
|---|---|
| Age (mean) (SD) (yr) | 49.2 (10.6) |
| Male sex | 6 (60%) |
| WHO grade | |
| III | 7 (70%) |
| IV | 3 (30%) |
| Extent of resection | |
| Biopsy | 2 (20%) |
| Subtotal | 3 (30%) |
| Gross total | 5 (50%) |
| IDH1/2 mutational status | |
| IDH wild-type | 4 (40%) |
| IDH mutant | 6 (60%) |
| MGMT promoter methylation status | |
| Unmethylated | 4 (40%) |
| Methylated | 4 (40%) |
| Unknown | 2 (20%) |
| Concurrent TMZ (median) (range) (% completed) | 100% (80%–100%) |
| Adjuvant TMZ (median) (range) (No. of cycles) | 6 (6–12) |
Note:—IDH indicates isocitrate dehydrogenase; MGMT, O6-methylguanine-DNA methyltransferase; TMZ, temozolomide.